TherapeuticsMD (TXMD) EBIT Margin (2011 - 2026)
TherapeuticsMD (TXMD) reported EBIT Margin of 99.86% for Q1 2026, up 22609.0% on a YoY basis from N/an in Q1 2025, and up 42.54% quarter-over-quarter from 173.8% in Q4 2025.
TherapeuticsMD (TXMD) EBIT Margin (2011 - 2026) Analysis & Trends
TherapeuticsMD has reported EBIT Margin for 16 years, with the latest figure at 99.86% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin rose 22609.0% year-over-year to 99.86%; the trailing twelve-month figure through Mar 2026 stood at 114.29% (up 20380.0% YoY), and the FY2025 full-year result was 145.27%, up 20181.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 99.86%, up from 173.8% in the prior quarter.
- The five-year high for EBIT Margin was 70.65% in Q4 2022, with the low at 4269.25% in Q2 2022.
- Historically, EBIT Margin has averaged 1081.72% across 5 years, with a median of 325.95% in 2025.
- Annual changes were most pronounced in 2022 — EBIT Margin slumped 411631 bps — and 2023, when it surged 370358 bps.
- TherapeuticsMD's EBIT Margin stood at 70.65% in 2022, then tumbled by 554 bps to 320.92% in 2023, then surged by 70 bps to 97.75% in 2024, then tumbled by 78 bps to 173.8% in 2025, then surged by 43 bps to 99.86% in 2026.
- The last three EBIT Margin figures came in at 99.86% (Q1 2026), 173.8% (Q4 2025), and 109.95% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | TherapeuticsMD | 21,527.64 | -8.40 Mn | - | -99.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.86% |
| Dec 31, 2025 | -173.80% |
| Sep 30, 2025 | -109.95% |
| Jun 30, 2025 | -73.00% |
| Mar 31, 2025 | -325.95% |
| Dec 31, 2024 | -97.75% |
| Sep 30, 2024 | -207.31% |
| Jun 30, 2024 | -1,191.88% |
| Mar 31, 2024 | -364.86% |
| Dec 31, 2023 | -320.92% |
| Sep 30, 2023 | -3,345.28% |
| Jun 30, 2023 | -565.68% |
| Mar 31, 2023 | -641.11% |
| Dec 31, 2022 | 70.65% |
| Sep 30, 2022 | -4,101.41% |
| Jun 30, 2022 | -4,269.25% |
| Mar 31, 2022 | -2,571.94% |
| Dec 31, 2021 | -189.48% |
| Sep 30, 2021 | -157.13% |
| Jun 30, 2021 | -152.95% |